PubMed ·

Major adverse cardiac events and mortality associated with ADHD and its treatment in adults with type 2 diabetes: a multi-national cohort study.

Zihan Dong, Yiling Zhou, Honghui Yao, Shengxin Liu, Aske Astrup, Anders Engeland, Le Gao, Malcolm B Gillies, Astrid Lunde, Yanli Zhang-James, Masako Araki, Isabell Brikell and 19 others

Published
Source
PubMed
Original
Read it at PubMed
Topics
Cardiology

In brief

ADHD's Hidden Risks in Diabetes

This study sheds light on the relationship between ADHD, its medication, and significant health risks like major adverse cardiac events (MACE) and mortality in adults with T2D. It highlights the need for integrated care approaches for these patients.

What they found: The study found that adults with T2D and ADHD have a significantly higher risk of all-cause mortality, with a hazard ratio of 2.42. However, the risk of major adverse cardiac events was not significantly elevated overall, with a hazard ratio of 1.04. Notably, ADHD medication use was associated with a higher rate of MACE specifically in those diagnosed with T2D at a younger age.

AI-written summary, not medical advice. Check anything you rely on against the original paper.

From the abstract

Attention-deficit/hyperactivity disorder (ADHD) has been linked to elevated risk of type 2 diabetes (T2D). However, the impact of ADHD and ADHD medication use on prognosis and health outcomes in T2D remains unclear.

The opening of the authors’ abstract. The rest is with PubMed.

Read the full abstract at PubMed

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Cardiology

Get the few papers worth your time in Cardiology every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics